Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders

Keyphrases

• Placebo 100%
• Childhood Autism 100%
• Divalproex Sodium 100%
• Adolescents with Autism Spectrum Disorder 100%
• Divalproex 66%
• Placebo Groups 33%
• Randomized Placebo-controlled Trial 33%
• Blood Levels 33%
• Repetitive Behavior 33%
• Autism Spectrum Disorder 33%
• Non-responders 33%
• Primary Outcome Measure 33%
• Clinical Global Impression 33%
• Valproate 33%
• Efficacy Index 33%
• Social Deficits 33%
• Language Impairment 33%
• Comorbid Symptoms 33%
• Aberrant Behavior Checklist 33%
• Active Groups 33%
• Verbal Intelligence 33%
• Lack of Efficacy 33%
• Independent Evaluator 33%
• Care Burden 33%
• Fisher's Exact 33%

Neuroscience

• Placebo 100%
• Autism Spectrum Disorder 100%
• Side Effect 50%
• Compulsive Behavior 25%
• Behavior Disorder 25%
• Psychopathology 25%

Psychology

• Autism Spectrum Disorder 100%
• Adolescence 100%
• Aberrant Behavior Checklist 25%
• Psychopathology 25%
• Language Deficit 25%